| Financial Year |
March 31 2023 |
| Monetary Funds |
438,896,354.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
278,542,533.96 |
| Accounts Receivable |
1,707,591,843.04 |
| Advances to Suppliers |
25,886,594.73 |
| Other Receivables |
168,726,338.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,156,752,202.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
261,641,306.47 |
| Total Current Assets |
4,094,879,833.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
61,171,560.06 |
| Investment Properties |
53,074,398.70 |
| Fixed Assetes |
2,873,336,967.65 |
| Under-construction Projects |
143,156,569.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
324,601,651.57 |
| R&D expenses |
-- |
| Goodwill |
793,681,277.66 |
| Long-Term Deferred and Prepaid Expenses |
566,321,747.57 |
| Deferred Income Tax Assets |
64,698,935.43 |
| Other Non-Current Assets |
206,490,111.17 |
| Sub-Total of Non-Current Assets |
5,135,760,463.14 |
| Total Assets |
9,230,640,296.43 |
| Short-Term Loans |
265,320,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
681,083,796.25 |
| Accounts Payable |
1,397,415,236.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
177,736,621.29 |
| Taxes Payable |
36,909,489.08 |
| Interest Payable |
-- |
| Dividend Payable |
1,002,662.25 |
| Other payables |
255,643,349.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
230,335,671.40 |
| Other Current Liabilities |
259,770,679.72 |
| Sub-Total of Current Liabilities |
3,314,426,387.03 |
| Long-term Loans |
412,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,923,959.10 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
57,046,225.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
605,172,640.60 |
| Total Liabilities |
3,919,599,027.63 |
| Paid-In Capital(Or Share Stock) |
528,878,866.00 |
| Capital Surplus |
2,680,354,203.79 |
| Surplus Reserve |
188,745,190.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,665,062,996.14 |
| Minority Stockholder's Interest |
248,000,012.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,063,041,255.93 |
| Owner's Equity（Stockholder's Equity） |
5,311,041,268.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,230,640,296.43 |
